Determination of an effective dose of eltenac and its comparison with that of flunixin meglumine in horses after experimentally induced carpitis

American Journal of Veterinary Research

Volumn 58, Issue 3, 1997, Pages 298-302

  Hamm, D ^a   Turchi, P ^a,c   Johnson, J C ^b   Lockwood, P W ^b   Thompson, K C ^b   Katz, T ^b  

^a Research for Animal Health   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Northwest Equine Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELTENAC; FLUNIXIN MEGLUMINE; UNCLASSIFIED DRUG;

ARTICLE; CARPAL TUNNEL SYNDROME; DRUG EFFICACY; HORSE; NONHUMAN; VETERINARY MEDICINE;

ANALYSIS OF VARIANCE; ANILINE COMPOUNDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARPAL BONES; CLONIXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FORELIMB; FREUND'S ADJUVANT; GAIT; HORSE DISEASES; HORSES; JOINT DISEASES; SYNOVIAL MEMBRANE; THIOPHENES;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0030993563     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. May SA, Lees P, Higgins AJ, et al. Inflammation: a clinical perspective. Vet Rec 1987;120(Suppl):514-517.
2. Prugner W, Huber R, Luhmann R. Eltenac, a new anti-inflammatory and analgesic drug for horses: clinical aspects. J Vet Pharmacol Ther 1991;14:193-199.
3. Higgins AJ, Lees P, Sedgwick AD. Development of equine models of inflammation. Vet Rec 1987:120(Suppl):517-522.
4. Mehta CR, Patel NR, Tsiatis AA. Exact significance testing to establish treatment equivalence with ordered categorical data. Biometrics 1984;40:819-825.